[
  {
    "ts": "2025-11-13T01:27:00+00:00",
    "headline": "3 Healthcare Stocks Topping a 2025 List of Dividend Yields",
    "summary": "Turn health into wealth with these three high-yielding dividend stocks.",
    "url": "https://www.fool.com/investing/2025/11/12/3-healthcare-stocks-topping-a-2025-list-of-dividen/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "fa15a7d6-932b-30e4-9233-4ce308ec27b2",
      "content": {
        "id": "fa15a7d6-932b-30e4-9233-4ce308ec27b2",
        "contentType": "STORY",
        "title": "3 Healthcare Stocks Topping a 2025 List of Dividend Yields",
        "description": "",
        "summary": "Turn health into wealth with these three high-yielding dividend stocks.",
        "pubDate": "2025-11-13T01:27:00Z",
        "displayTime": "2025-11-13T01:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1e0f427fa53007e24b9457b0c759b3e6",
          "originalWidth": 1400,
          "originalHeight": 937,
          "caption": "A stethoscope sits atop $100 bills laid out on a table.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XgrBi89kZjh6dZFYMGo5OA--~B/aD05Mzc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1e0f427fa53007e24b9457b0c759b3e6.cf.webp",
              "width": 1400,
              "height": 937,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hHoMDrSXZL5QAlzVYfaoQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1e0f427fa53007e24b9457b0c759b3e6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/12/3-healthcare-stocks-topping-a-2025-list-of-dividen/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-healthcare-stocks-topping-2025-012700712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "XRAY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T09:55:00+00:00",
    "headline": "Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?",
    "summary": "Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.",
    "url": "https://www.fool.com/investing/2025/11/13/forget-pfizer-buy-magnificent-drug-stock/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "ddac82d5-7cca-3ff5-bd66-72b1c4d36c5b",
      "content": {
        "id": "ddac82d5-7cca-3ff5-bd66-72b1c4d36c5b",
        "contentType": "STORY",
        "title": "Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?",
        "description": "",
        "summary": "Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.",
        "pubDate": "2025-11-13T09:55:00Z",
        "displayTime": "2025-11-13T09:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/3a48e52c797c1a215add24a2a50cd8a6",
          "originalWidth": 1199,
          "originalHeight": 711,
          "caption": "A person with their hands up in frustration.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bPKERggN_Ctl_MGeOY3Myw--~B/aD03MTE7dz0xMTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/3a48e52c797c1a215add24a2a50cd8a6.cf.webp",
              "width": 1199,
              "height": 711,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WYbca0fos3_KTGz6FtsqlA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/3a48e52c797c1a215add24a2a50cd8a6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/forget-pfizer-buy-magnificent-drug-stock/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/forget-pfizer-buy-magnificent-drug-095500549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T12:01:09+00:00",
    "headline": "Inside Yahoo Finance Invest 2025: Elon Musk's $1 trillion pay package, crypto cracks, and AI bubbles",
    "summary": "If you love investing or want to love investing, Yahoo Finance's annual Invest event is here to help!",
    "url": "https://finance.yahoo.com/news/inside-yahoo-finance-invest-2025-elon-musks-1-trillion-pay-package-crypto-cracks-and-ai-bubbles-120109950.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "d4716c13-ca1e-48f5-bd3e-7150c75c0270",
      "content": {
        "id": "d4716c13-ca1e-48f5-bd3e-7150c75c0270",
        "contentType": "STORY",
        "title": "Inside Yahoo Finance Invest 2025: Elon Musk's $1 trillion pay package, crypto cracks, and AI bubbles",
        "description": "",
        "summary": "If you love investing or want to love investing, Yahoo Finance's annual Invest event is here to help!",
        "pubDate": "2025-11-13T12:01:09Z",
        "displayTime": "2025-11-13T12:01:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/1fd2a390-a93e-11f0-af7b-3a2e18b77fcc",
          "originalWidth": 561,
          "originalHeight": 316,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6K.EleSfORqVAvfPmbIgoQ--~B/aD0zMTY7dz01NjE7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/1fd2a390-a93e-11f0-af7b-3a2e18b77fcc.cf.webp",
              "width": 561,
              "height": 316,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PuXVQ74oon_G1bzkXESUUg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/1fd2a390-a93e-11f0-af7b-3a2e18b77fcc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/inside-yahoo-finance-invest-2025-elon-musks-1-trillion-pay-package-crypto-cracks-and-ai-bubbles-120109950.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/inside-yahoo-finance-invest-2025-elon-musks-1-trillion-pay-package-crypto-cracks-and-ai-bubbles-120109950.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "HUT"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "ABTC"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "DAL"
            },
            {
              "symbol": "ETOR"
            },
            {
              "symbol": "TFC"
            },
            {
              "symbol": "COIN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T11:50:00+00:00",
    "headline": "Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results",
    "summary": "Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today reported financial results for the quarter ended September 30, 2025, and provided a financial and business update.",
    "url": "https://finance.yahoo.com/news/protalix-biotherapeutics-reports-third-quarter-115000712.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "4c30cf0a-d188-3a3c-95d4-cb81b34806ea",
      "content": {
        "id": "4c30cf0a-d188-3a3c-95d4-cb81b34806ea",
        "contentType": "STORY",
        "title": "Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results",
        "description": "",
        "summary": "Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today reported financial results for the quarter ended September 30, 2025, and provided a financial and business update.",
        "pubDate": "2025-11-13T11:50:00Z",
        "displayTime": "2025-11-13T11:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f2174d5c59bc5e34e9e5ea6a94c7eeba",
          "originalWidth": 400,
          "originalHeight": 121,
          "caption": "Protalix Biotherapeutics Logo (PRNewsfoto/Protalix Biotherapeutics Inc)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gKHaK2aaXdNF9jevNdwC4A--~B/aD0xMjE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f2174d5c59bc5e34e9e5ea6a94c7eeba.cf.webp",
              "width": 400,
              "height": 121,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a9XClvTONPq7IISlgdiW6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f2174d5c59bc5e34e9e5ea6a94c7eeba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/protalix-biotherapeutics-reports-third-quarter-115000712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/protalix-biotherapeutics-reports-third-quarter-115000712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLX"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T11:23:07+00:00",
    "headline": "CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value",
    "summary": "The WifOR Institute’s ‘handprint’ quantifies positive socioeconomic impact of pharma products, positing a sustainability metric.",
    "url": "https://www.pharmaceutical-technology.com/news/cphi-2025-handprint-metric-bridges-pharma-sustainability-and-economic-value/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "4573853d-fedb-3c4a-affa-9b7b6d701c92",
      "content": {
        "id": "4573853d-fedb-3c4a-affa-9b7b6d701c92",
        "contentType": "STORY",
        "title": "CPHI 2025: ‘handprint’ metric bridges pharma sustainability and economic value",
        "description": "",
        "summary": "The WifOR Institute’s ‘handprint’ quantifies positive socioeconomic impact of pharma products, positing a sustainability metric.",
        "pubDate": "2025-11-13T11:23:07Z",
        "displayTime": "2025-11-13T11:23:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/e738fb73327688d20bef46b07d155b2a",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "The WifOR Institute’s ‘handprint’ metric has been used by pharma supplier Evonik to assess the broader socioeconomic impact of their PhytoChol vaccine product. Credit: Photo by wh1600 / E+ via Getty Images.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qgd2Wv4I.79_gZ7_7jjQyw--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/e738fb73327688d20bef46b07d155b2a.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IMnZ6rFZ1xbron68Qp1Asg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/e738fb73327688d20bef46b07d155b2a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/cphi-2025-handprint-metric-bridges-pharma-sustainability-and-economic-value/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cphi-2025-handprint-metric-bridges-112307936.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T14:45:38+00:00",
    "headline": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "8797ed93-cd75-34fe-b872-cf042d802372",
      "content": {
        "id": "8797ed93-cd75-34fe-b872-cf042d802372",
        "contentType": "STORY",
        "title": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
        "pubDate": "2025-11-13T14:45:38Z",
        "displayTime": "2025-11-13T14:45:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DASH"
            },
            {
              "symbol": "SSTI"
            },
            {
              "symbol": "CRCL"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "KRRO"
            },
            {
              "symbol": "DLTR"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "COO"
            },
            {
              "symbol": "BKNG"
            },
            {
              "symbol": "AZO"
            },
            {
              "symbol": "LWAY"
            },
            {
              "symbol": "FAST"
            },
            {
              "symbol": "VITL"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "RKT"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T17:14:56+00:00",
    "headline": "Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market",
    "summary": "Pfizer CEO Albert Bourla told Yahoo Finance that Pfizer has a \"right to win\" on the obesity drugs that have become a major market.",
    "url": "https://finance.yahoo.com/news/pfizer-ceo-albert-bourla-says-aggressive-bid-for-metsera-reflects-companys-right-to-win-obesity-market-171456959.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "4eb6f877-7591-4d46-a874-6608e9923dde",
      "content": {
        "id": "4eb6f877-7591-4d46-a874-6608e9923dde",
        "contentType": "STORY",
        "title": "Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market",
        "description": "",
        "summary": "Pfizer CEO Albert Bourla told Yahoo Finance that Pfizer has a \"right to win\" on the obesity drugs that have become a major market.",
        "pubDate": "2025-11-13T17:14:56Z",
        "displayTime": "2025-11-13T17:14:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/d07cbc50-c08e-11f0-bb77-ee97f9f46288",
          "originalWidth": 5327,
          "originalHeight": 3551,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5QHKyc4nETYI_CKxDSpDKw--~B/aD0zNTUxO3c9NTMyNzthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/d07cbc50-c08e-11f0-bb77-ee97f9f46288.cf.webp",
              "width": 5327,
              "height": 3551,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IidjbYJIrf4G8eG3NbnszQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/d07cbc50-c08e-11f0-bb77-ee97f9f46288.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-albert-bourla-says-aggressive-bid-for-metsera-reflects-companys-right-to-win-obesity-market-171456959.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-albert-bourla-says-aggressive-bid-for-metsera-reflects-companys-right-to-win-obesity-market-171456959.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T16:26:00+00:00",
    "headline": "Pfizer Completes Acquisition of Metsera",
    "summary": "NEW YORK, November 13, 2025--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.",
    "url": "https://finance.yahoo.com/news/pfizer-completes-acquisition-metsera-162600502.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "1853cc2b-72fe-3423-9b10-a2657b61e193",
      "content": {
        "id": "1853cc2b-72fe-3423-9b10-a2657b61e193",
        "contentType": "STORY",
        "title": "Pfizer Completes Acquisition of Metsera",
        "description": "",
        "summary": "NEW YORK, November 13, 2025--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.",
        "pubDate": "2025-11-13T16:26:00Z",
        "displayTime": "2025-11-13T16:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/642df4c0df76d58d09ad907959e705a1",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7sfuJT6vjIQAgxGEBIaVlg--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/642df4c0df76d58d09ad907959e705a1.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6AvFZcgeCYdeRdbWl1S1qQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/642df4c0df76d58d09ad907959e705a1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-completes-acquisition-metsera-162600502.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-completes-acquisition-metsera-162600502.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T18:15:32+00:00",
    "headline": "Future of medicine will be profoundly impacted by AI: Pfizer CEO",
    "summary": "Pfizer (PFE) chairman and CEO, Albert Bourla, sits down with Yahoo Finance Executive Editor Brian Sozzi to discuss the future of medicine and pharmaceuticals, and what impact he believes artificial intelligence (AI) will have.&nbsp; For full interviews, highlights, and key insights, check out more from&nbsp;Yahoo Finance Invest.",
    "url": "https://finance.yahoo.com/video/future-medicine-profoundly-impacted-ai-181532359.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "8971d147-2b1d-3b07-b766-ca0b122ba0fb",
      "content": {
        "id": "8971d147-2b1d-3b07-b766-ca0b122ba0fb",
        "contentType": "VIDEO",
        "title": "Future of medicine will be profoundly impacted by AI: Pfizer CEO",
        "description": "<p>Pfizer (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>) chairman and CEO, Albert Bourla, sits down with Yahoo Finance Executive Editor <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/author/brian-sozzi/\">Brian Sozzi </a>to discuss the future of medicine and pharmaceuticals, and what impact he believes artificial intelligence (AI) will have. </p>\n<p>For full interviews, highlights, and key insights, check out more from <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/topic/yf-invest/\">Yahoo Finance Invest</a>.</p>",
        "summary": "Pfizer (PFE) chairman and CEO, Albert Bourla, sits down with Yahoo Finance Executive Editor Brian Sozzi to discuss the future of medicine and pharmaceuticals, and what impact he believes artificial intelligence (AI) will have.&nbsp; For full interviews, highlights, and key insights, check out more from&nbsp;Yahoo Finance Invest.",
        "pubDate": "2025-11-13T18:15:32Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/7022c6b0-c0bb-11f0-bfd6-209c32173549",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eLykfPZ2m0.xpfkCFy8yqQ--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/7022c6b0-c0bb-11f0-bfd6-209c32173549.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yZNVWD1hObBK6_WuPPXE4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/7022c6b0-c0bb-11f0-bfd6-209c32173549.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/future-medicine-profoundly-impacted-ai-181532359.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/future-medicine-profoundly-impacted-ai-181532359.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T16:58:14+00:00",
    "headline": "Pfizer plans to enter GLP-1 space by 2028, CEO explains",
    "summary": "Pfizer (PFE) chairman and CEO, Albert Bourla, sits down with Yahoo Finance Executive Editor Brian Sozzi to share that Pfizer will enter the obesity market by 2028 after paying $10B to acquire Metsera (MTSR). The drugmaker won out over rival Novo Nordisk (NVO) in its bid for the company. For full interviews, highlights, and key insights, check out more from&nbsp;Yahoo Finance Invest.",
    "url": "https://finance.yahoo.com/video/pfizer-plans-enter-glp-1-165814799.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "b0623738-376e-3a94-a29a-327988959dd5",
      "content": {
        "id": "b0623738-376e-3a94-a29a-327988959dd5",
        "contentType": "VIDEO",
        "title": "Pfizer plans to enter GLP-1 space by 2028, CEO explains",
        "description": "<p>Pfizer (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>) chairman and CEO, Albert Bourla, sits down with Yahoo Finance Executive Editor <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/author/brian-sozzi/\">Brian Sozzi </a>to share that Pfizer will enter the obesity market by 2028 after paying $10B to acquire Metsera (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/MTSR\">MTSR</a>). The drugmaker won out over rival Novo Nordisk (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/NVO\">NVO</a>) in its bid for the company.</p>\n<p>For full interviews, highlights, and key insights, check out more from <a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/topic/yf-invest/\">Yahoo Finance Invest</a>.</p>",
        "summary": "Pfizer (PFE) chairman and CEO, Albert Bourla, sits down with Yahoo Finance Executive Editor Brian Sozzi to share that Pfizer will enter the obesity market by 2028 after paying $10B to acquire Metsera (MTSR). The drugmaker won out over rival Novo Nordisk (NVO) in its bid for the company. For full interviews, highlights, and key insights, check out more from&nbsp;Yahoo Finance Invest.",
        "pubDate": "2025-11-13T16:58:14Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/253c20c0-c0b0-11f0-976b-c7a40fc0e8a8",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QymuhQqJ6WWr19drl43wbg--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/253c20c0-c0b0-11f0-976b-c7a40fc0e8a8.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Tq5_l6mWUZ5RgTRph2lqBA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/253c20c0-c0b0-11f0-976b-c7a40fc0e8a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/pfizer-plans-enter-glp-1-165814799.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/pfizer-plans-enter-glp-1-165814799.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T18:24:42+00:00",
    "headline": "Pfizer Dumps BioNTech Stake as Obesity Gold Rush Heats Up",
    "summary": "$508M share sale marks end of a Covid-era alliance--just as Pfizer doubles down on weight-loss moonshots",
    "url": "https://finance.yahoo.com/news/pfizer-dumps-biontech-stake-obesity-182442413.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "573b83fe-a12f-3072-a3da-4f9d0570ad02",
      "content": {
        "id": "573b83fe-a12f-3072-a3da-4f9d0570ad02",
        "contentType": "STORY",
        "title": "Pfizer Dumps BioNTech Stake as Obesity Gold Rush Heats Up",
        "description": "",
        "summary": "$508M share sale marks end of a Covid-era alliance--just as Pfizer doubles down on weight-loss moonshots",
        "pubDate": "2025-11-13T18:24:42Z",
        "displayTime": "2025-11-13T18:24:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vu.kxzmN7yCA.wz8Cs.cHg--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Brb0J12XOUXl4lathAg3vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-dumps-biontech-stake-obesity-182442413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-dumps-biontech-stake-obesity-182442413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T18:00:23+00:00",
    "headline": "Top Midday Stories: Disney Shares Fall After Revenue Miss; Verizon to Cut Workforce by About 15,000 Jobs",
    "summary": "All three major US stock indexes were down after midday trading Thursday, following President Donald",
    "url": "https://finance.yahoo.com/news/top-midday-stories-disney-shares-180023401.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "71635212-b60b-3a4c-a94b-bab9eb9fd47d",
      "content": {
        "id": "71635212-b60b-3a4c-a94b-bab9eb9fd47d",
        "contentType": "STORY",
        "title": "Top Midday Stories: Disney Shares Fall After Revenue Miss; Verizon to Cut Workforce by About 15,000 Jobs",
        "description": "",
        "summary": "All three major US stock indexes were down after midday trading Thursday, following President Donald",
        "pubDate": "2025-11-13T18:00:23Z",
        "displayTime": "2025-11-13T18:00:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-disney-shares-180023401.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-disney-shares-180023401.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VZ"
            },
            {
              "symbol": "DIS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T18:58:53+00:00",
    "headline": "Activist investor Jeff Smith: How Starboard 'lights a fire' under Corporate America",
    "summary": "Starboard’s Jeff Smith says activism isn’t about destruction — it’s about discipline, efficiency, and motivating complacent CEOs.",
    "url": "https://finance.yahoo.com/news/activist-investor-jeff-smith-how-starboard-lights-a-fire-under-corporate-america-185853829.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "a41ac3f6-595a-4f88-a66f-fc7d53aaf5b3",
      "content": {
        "id": "a41ac3f6-595a-4f88-a66f-fc7d53aaf5b3",
        "contentType": "STORY",
        "title": "Activist investor Jeff Smith: How Starboard 'lights a fire' under Corporate America",
        "description": "",
        "summary": "Starboard’s Jeff Smith says activism isn’t about destruction — it’s about discipline, efficiency, and motivating complacent CEOs.",
        "pubDate": "2025-11-13T18:58:53Z",
        "displayTime": "2025-11-13T18:58:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/054895d0-ba6d-11f0-9e6a-d0c9820131e7",
          "originalWidth": 5305,
          "originalHeight": 3537,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_rAQ0xSJ96CsEHhrTFXrKw--~B/aD0zNTM3O3c9NTMwNTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/054895d0-ba6d-11f0-9e6a-d0c9820131e7.cf.webp",
              "width": 5305,
              "height": 3537,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sJ2cojKNcuXIlSA9R74.Bw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/054895d0-ba6d-11f0-9e6a-d0c9820131e7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/activist-investor-jeff-smith-how-starboard-lights-a-fire-under-corporate-america-185853829.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/activist-investor-jeff-smith-how-starboard-lights-a-fire-under-corporate-america-185853829.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ADSK"
            },
            {
              "symbol": "QRVO"
            },
            {
              "symbol": "DRI"
            },
            {
              "symbol": "KDP"
            },
            {
              "symbol": "NWSA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "FLR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T17:04:31+00:00",
    "headline": "Pfizer CEO: AI will help with medicine's next big breakthrough",
    "summary": "Fresh off Pfizer's (PFE) $10 billion battle to acquire Metsera (MTSR), Pfizer chairman and CEO Albert Bourla tells Yahoo Finance Executive Editor Brian Sozzi that the future for the pharmaceutical giant is bright. The company plans to enter the GLP-1 space by 2028 and aims to become a leader in the obesity market. Bourla also notes that the next big breakthrough in medicine could be aided by the use of artificial intelligence and discusses Pfizer's relationship with the White House. For full interviews, highlights, and key insights, check out more from&nbsp;Yahoo Finance Invest.",
    "url": "https://finance.yahoo.com/video/pfizer-ceo-ai-help-medicines-170431756.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "c1ad8c43-156b-356c-b3b8-e06a17bfaaa5",
      "content": {
        "id": "c1ad8c43-156b-356c-b3b8-e06a17bfaaa5",
        "contentType": "VIDEO",
        "title": "Pfizer CEO: AI will help with medicine's next big breakthrough",
        "description": "<p>Fresh off Pfizer's (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>) $10 billion battle to acquire Metsera (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/MTSR\">MTSR</a>), Pfizer chairman and CEO Albert Bourla tells Yahoo Finance Executive Editor <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/author/brian-sozzi/\">Brian Sozzi </a>that the future for the pharmaceutical giant is bright. The company plans to enter the GLP-1 space by 2028 and aims to become a leader in the obesity market.</p>\n<p>Bourla also notes that the next big breakthrough in medicine could be aided by the use of artificial intelligence and discusses Pfizer's relationship with the White House.</p>\n<p>For full interviews, highlights, and key insights, check out more from <a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/topic/yf-invest/\">Yahoo Finance Invest</a>.</p>",
        "summary": "Fresh off Pfizer's (PFE) $10 billion battle to acquire Metsera (MTSR), Pfizer chairman and CEO Albert Bourla tells Yahoo Finance Executive Editor Brian Sozzi that the future for the pharmaceutical giant is bright. The company plans to enter the GLP-1 space by 2028 and aims to become a leader in the obesity market. Bourla also notes that the next big breakthrough in medicine could be aided by the use of artificial intelligence and discusses Pfizer's relationship with the White House. For full interviews, highlights, and key insights, check out more from&nbsp;Yahoo Finance Invest.",
        "pubDate": "2025-11-13T17:04:31Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/990bcd70-c0b0-11f0-bcef-86bfbbd12efd",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L4t1xD0FZBTGp6uSaZwhcw--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/990bcd70-c0b0-11f0-bcef-86bfbbd12efd.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k6uHN4Up2ci84WNbgp0paA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/990bcd70-c0b0-11f0-bcef-86bfbbd12efd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/pfizer-ceo-ai-help-medicines-170431756.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/pfizer-ceo-ai-help-medicines-170431756.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T20:12:42+00:00",
    "headline": "Pfizer CEO says RFK Jr. wasn't his 'first choice' for HHS Secretary",
    "summary": "Pfizer CEO says RFK Jr.'s appointment was not up to him, though he has found common ground with the vaccine skeptic.",
    "url": "https://finance.yahoo.com/news/pfizer-ceo-says-rfk-jr-wasnt-his-first-choice-for-hhs-secretary-201242363.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "f77c32d9-76f6-4bbe-8cb0-d039f2490b52",
      "content": {
        "id": "f77c32d9-76f6-4bbe-8cb0-d039f2490b52",
        "contentType": "STORY",
        "title": "Pfizer CEO says RFK Jr. wasn't his 'first choice' for HHS Secretary",
        "description": "",
        "summary": "Pfizer CEO says RFK Jr.'s appointment was not up to him, though he has found common ground with the vaccine skeptic.",
        "pubDate": "2025-11-13T20:12:42Z",
        "displayTime": "2025-11-13T20:12:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/f3c720a0-c0c1-11f0-9b9f-dce56e2bd021",
          "originalWidth": 8256,
          "originalHeight": 5504,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JwSMy0xviAPeCXifAECJeQ--~B/aD01NTA0O3c9ODI1NjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/f3c720a0-c0c1-11f0-9b9f-dce56e2bd021.cf.webp",
              "width": 8256,
              "height": 5504,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sd7WHT4ntQlnSYLDETpCYA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/f3c720a0-c0c1-11f0-9b9f-dce56e2bd021.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-says-rfk-jr-wasnt-his-first-choice-for-hhs-secretary-201242363.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-says-rfk-jr-wasnt-his-first-choice-for-hhs-secretary-201242363.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T19:38:31+00:00",
    "headline": "Pfizer completes Metsera acquisition in deal worth up to $10 bn",
    "summary": "US drugmaker Pfizer said Thursday that it has completed its acquisition of biotech firm Metsera, closing a deal worth up to $10 billion after a fierce bidding war.It had offered to acquire Metsera for up to $86.25 per share, making the deal worth around $10 billion.",
    "url": "https://finance.yahoo.com/news/pfizer-completes-metsera-acquisition-deal-193831170.html",
    "source": "AFP",
    "provider": "yfinance",
    "raw": {
      "id": "04858ac9-7cdf-3d4b-b4d5-065122d94de0",
      "content": {
        "id": "04858ac9-7cdf-3d4b-b4d5-065122d94de0",
        "contentType": "STORY",
        "title": "Pfizer completes Metsera acquisition in deal worth up to $10 bn",
        "description": "",
        "summary": "US drugmaker Pfizer said Thursday that it has completed its acquisition of biotech firm Metsera, closing a deal worth up to $10 billion after a fierce bidding war.It had offered to acquire Metsera for up to $86.25 per share, making the deal worth around $10 billion.",
        "pubDate": "2025-11-13T19:38:31Z",
        "displayTime": "2025-11-13T19:38:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/afp.com/4a6f86ad673fa0e01dbc0ea8510a31b1",
          "originalWidth": 768,
          "originalHeight": 512,
          "caption": "Pfizer has completed its acquisition of biotech firm Metsera (ANGELA WEISS)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9wpH2ca1uC5Re7sSkeWpUg--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/4a6f86ad673fa0e01dbc0ea8510a31b1.cf.webp",
              "width": 768,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6fw3Jmincl6ZQSIHTbDClw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/4a6f86ad673fa0e01dbc0ea8510a31b1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "AFP",
          "url": "http://www.afp.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-completes-metsera-acquisition-deal-193831170.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-completes-metsera-acquisition-deal-193831170.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T19:20:00+00:00",
    "headline": "Healthcare Stocks Are Blowing Past the S&P 500. What Could Be Behind the Rally.",
    "summary": "The sector is up almost 7% since the start of November, while the broader market is down more than 1%.",
    "url": "https://www.barrons.com/articles/healthcare-stocks-unitedhealth-pfizer-rally-26bcf393?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e5486cd4-07b5-3245-af27-620df54fb499",
      "content": {
        "id": "e5486cd4-07b5-3245-af27-620df54fb499",
        "contentType": "STORY",
        "title": "Healthcare Stocks Are Blowing Past the S&P 500. What Could Be Behind the Rally.",
        "description": "",
        "summary": "The sector is up almost 7% since the start of November, while the broader market is down more than 1%.",
        "pubDate": "2025-11-13T19:20:00Z",
        "displayTime": "2025-11-13T19:20:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e5486cd4-07b5-3245-af27-620df54fb499/healthcare-stocks-are-blowing.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/674a273b387e6dcaecf3255e826a3db8",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DJd9e1P.c4iyluMzjNDlIQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/674a273b387e6dcaecf3255e826a3db8.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fNRt4hXdrI6nN9knDt8Qvg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/674a273b387e6dcaecf3255e826a3db8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/healthcare-stocks-unitedhealth-pfizer-rally-26bcf393?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "MAGS"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T20:44:42+00:00",
    "headline": "Sector Update: Health Care Stocks Edge Higher Late Afternoon",
    "summary": "Health care stocks edged up late Thursday afternoon, with the NYSE Health Care Index and the Health",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-edge-204442127.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "7347dd31-06bf-3499-8f20-e8a1a7365840",
      "content": {
        "id": "7347dd31-06bf-3499-8f20-e8a1a7365840",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Edge Higher Late Afternoon",
        "description": "",
        "summary": "Health care stocks edged up late Thursday afternoon, with the NYSE Health Care Index and the Health",
        "pubDate": "2025-11-13T20:44:42Z",
        "displayTime": "2025-11-13T20:44:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-edge-204442127.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-edge-204442127.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRSN"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "DAWN"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T18:45:00+00:00",
    "headline": "BMY's Growth Portfolio Shines in Q3: Turning Point Ahead?",
    "summary": "Bristol Myers' strong Q3 growth portfolio, led by Opdivo and Reblozyl, helped counter declines in legacy drug sales.",
    "url": "https://finance.yahoo.com/news/bmys-growth-portfolio-shines-q3-184500604.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "36b4a5e1-d651-337d-80df-dbf2e8a75489",
      "content": {
        "id": "36b4a5e1-d651-337d-80df-dbf2e8a75489",
        "contentType": "STORY",
        "title": "BMY's Growth Portfolio Shines in Q3: Turning Point Ahead?",
        "description": "",
        "summary": "Bristol Myers' strong Q3 growth portfolio, led by Opdivo and Reblozyl, helped counter declines in legacy drug sales.",
        "pubDate": "2025-11-13T18:45:00Z",
        "displayTime": "2025-11-13T18:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmys-growth-portfolio-shines-q3-184500604.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmys-growth-portfolio-shines-q3-184500604.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T22:38:00+00:00",
    "headline": "Novo Nordisk A/S: Candidate for the Board of Directors will not seek election",
    "summary": "Bagsværd, Denmark, 13 November 2025 – Today, it was announced that Mikael Dolsten will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November 2025, as otherwise announced in the notice convening the Extraordinary General Meeting. Earlier today, Mikael Dolsten, who most recently served as the Head of R&D at Pfizer, informed Novo Nordisk that, in spite of his desire to join, he has decided to withdraw his candidacy to the Novo Nordisk Board of Dire",
    "url": "https://finance.yahoo.com/news/novo-nordisk-candidate-board-directors-223800627.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d40f5195-b898-37b7-9fbe-3f9681dd5017",
      "content": {
        "id": "d40f5195-b898-37b7-9fbe-3f9681dd5017",
        "contentType": "STORY",
        "title": "Novo Nordisk A/S: Candidate for the Board of Directors will not seek election",
        "description": "",
        "summary": "Bagsværd, Denmark, 13 November 2025 – Today, it was announced that Mikael Dolsten will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November 2025, as otherwise announced in the notice convening the Extraordinary General Meeting. Earlier today, Mikael Dolsten, who most recently served as the Head of R&D at Pfizer, informed Novo Nordisk that, in spite of his desire to join, he has decided to withdraw his candidacy to the Novo Nordisk Board of Dire",
        "pubDate": "2025-11-13T22:38:00Z",
        "displayTime": "2025-11-13T22:38:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/390a90dca9ab1da0d2c89c641db85b9e",
          "originalWidth": 600,
          "originalHeight": 427,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cBWaijHhCwTpKXQaX3aOwQ--~B/aD00Mjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/390a90dca9ab1da0d2c89c641db85b9e.cf.webp",
              "width": 600,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KUVppJinUZmSka5dRXSyuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/390a90dca9ab1da0d2c89c641db85b9e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-candidate-board-directors-223800627.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-candidate-board-directors-223800627.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T19:30:00+00:00",
    "headline": "RFK Jr. would not have been my HHS pick: Pfizer CEO",
    "summary": "Health and Human Services Secretary Robert F. Kennedy, Jr. has come under fire for his views on vaccines. In an interview with Yahoo Finance, Pfizer (PFE) CEO Albert Bourla says that Kennedy wouldn't have been his pick to lead HHS. Find out why in the video above. Be sure to watch the full interview with Albert Bourla. For full interviews, highlights, and key insights, check out more from&nbsp;Yahoo Finance Invest.",
    "url": "https://finance.yahoo.com/video/rfk-jr-not-hhs-pick-193000325.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "184b26e6-729c-31bf-a4f1-b65daccd03b3",
      "content": {
        "id": "184b26e6-729c-31bf-a4f1-b65daccd03b3",
        "contentType": "VIDEO",
        "title": "RFK Jr. would not have been my HHS pick: Pfizer CEO",
        "description": "<p>Health and Human Services Secretary Robert F. Kennedy, Jr. has come under fire for his views on vaccines. In an interview with Yahoo Finance, Pfizer (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>) CEO Albert Bourla says that Kennedy wouldn't have been his pick to lead HHS. Find out why in the video above.</p>\n<p>Be sure to <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/video/pfizer-ceo-ai-help-medicines-170431756.html\">watch the full interview</a> with Albert Bourla.</p>\n<p>For full interviews, highlights, and key insights, check out more from <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/topic/yf-invest/\">Yahoo Finance Invest</a>.</p>",
        "summary": "Health and Human Services Secretary Robert F. Kennedy, Jr. has come under fire for his views on vaccines. In an interview with Yahoo Finance, Pfizer (PFE) CEO Albert Bourla says that Kennedy wouldn't have been his pick to lead HHS. Find out why in the video above. Be sure to watch the full interview with Albert Bourla. For full interviews, highlights, and key insights, check out more from&nbsp;Yahoo Finance Invest.",
        "pubDate": "2025-11-13T19:30:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/411763a0-c0b9-11f0-bcea-4cd59121bbd2",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wmmoPl2Ls0RV4yEcELaeng--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/411763a0-c0b9-11f0-bcea-4cd59121bbd2.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/p.urt6Ls7yRDL0Vk5Iwyrg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/411763a0-c0b9-11f0-bcea-4cd59121bbd2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/rfk-jr-not-hhs-pick-193000325.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/rfk-jr-not-hhs-pick-193000325.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T23:43:30+00:00",
    "headline": "Pfizer slashes stake in COVID vaccine partner BioNTech",
    "summary": "(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly",
    "url": "https://ca.finance.yahoo.com/news/pfizer-slashes-stake-covid-vaccine-234330282.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "afc8314a-d480-3a16-ac4f-08110853762b",
      "content": {
        "id": "afc8314a-d480-3a16-ac4f-08110853762b",
        "contentType": "STORY",
        "title": "Pfizer slashes stake in COVID vaccine partner BioNTech",
        "description": "",
        "summary": "(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly",
        "pubDate": "2025-11-13T23:43:30Z",
        "displayTime": "2025-11-13T23:43:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/16a685f572c861399546c157bb548633",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "The Pfizer logo is seen in this illustration taken August 3, 2025. REUTERS/Dado Ruvic/Illustration",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yf_UZ4HfOae7spH6V75J3g--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/16a685f572c861399546c157bb548633.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G7Zsd7h7tNZIUs6bHGH2yA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/16a685f572c861399546c157bb548633.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/pfizer-slashes-stake-covid-vaccine-234330282.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-slashes-stake-covid-vaccine-234330282.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T23:38:05+00:00",
    "headline": "Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race",
    "summary": "(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday.",
    "url": "https://finance.yahoo.com/news/pfizers-ex-r-d-chief-232004327.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "bf3bd391-c7d0-3eb7-b3b2-51173a4a21f5",
      "content": {
        "id": "bf3bd391-c7d0-3eb7-b3b2-51173a4a21f5",
        "contentType": "STORY",
        "title": "Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race",
        "description": "",
        "summary": "(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday.",
        "pubDate": "2025-11-13T23:38:05Z",
        "displayTime": "2025-11-13T23:38:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/b7d85e999daee1d3d497f81198ad0472",
          "originalWidth": 800,
          "originalHeight": 514,
          "caption": "FILE PHOTO: Logos of Pfizer at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/U7i6Y3s9pUU31e91d3EIvA--~B/aD01MTQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b7d85e999daee1d3d497f81198ad0472.cf.webp",
              "width": 800,
              "height": 514,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/44CMy.KXBO_vIrE2Jszybw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b7d85e999daee1d3d497f81198ad0472.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-ex-r-d-chief-232004327.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-ex-r-d-chief-232004327.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T17:18:14+00:00",
    "headline": "Pfizer completes up to $10 billion acquisition of Metsera",
    "summary": "By Kamal Choudhury and Mariam Sunny (Reuters) -Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold in the fast-growing obesity",
    "url": "https://finance.yahoo.com/news/metsera-shareholders-vote-10-billion-142059178.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "928d0226-0a35-3344-a222-c96d66e54b93",
      "content": {
        "id": "928d0226-0a35-3344-a222-c96d66e54b93",
        "contentType": "STORY",
        "title": "Pfizer completes up to $10 billion acquisition of Metsera",
        "description": "",
        "summary": "By Kamal Choudhury and Mariam Sunny (Reuters) -Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold in the fast-growing obesity",
        "pubDate": "2025-11-13T17:18:14Z",
        "displayTime": "2025-11-13T17:18:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/0590a0779ad8711d8b5a3bec40eebd23",
          "originalWidth": 800,
          "originalHeight": 473,
          "caption": "Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f20k4dUWDAYUWiPg8M8ADw--~B/aD00NzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/0590a0779ad8711d8b5a3bec40eebd23.cf.webp",
              "width": 800,
              "height": 473,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fVeJyDnv_4zVrsTVPUnmOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/0590a0779ad8711d8b5a3bec40eebd23.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/metsera-shareholders-vote-10-billion-142059178.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/metsera-shareholders-vote-10-billion-142059178.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T17:07:29+00:00",
    "headline": "What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?",
    "summary": "(Reuters) -Pfizer said on Thursday it completed an acquisition worth up to $10 billion of biotech firm Metsera after winning shareholder approval, securing a path into the fast-growing obesity",
    "url": "https://finance.yahoo.com/news/factbox-metsera-target-pfizers-novo-170136393.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "aea97c0e-149c-332c-aa71-b6ce97e4b3a5",
      "content": {
        "id": "aea97c0e-149c-332c-aa71-b6ce97e4b3a5",
        "contentType": "STORY",
        "title": "What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?",
        "description": "",
        "summary": "(Reuters) -Pfizer said on Thursday it completed an acquisition worth up to $10 billion of biotech firm Metsera after winning shareholder approval, securing a path into the fast-growing obesity",
        "pubDate": "2025-11-13T17:07:29Z",
        "displayTime": "2025-11-13T17:07:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/2c3245b488f21f067bff7b3714297728",
          "originalWidth": 800,
          "originalHeight": 578,
          "caption": "A logo of Pfizer at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FBi9JthyHSZAUvkU9kN8FQ--~B/aD01Nzg7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/2c3245b488f21f067bff7b3714297728.cf.webp",
              "width": 800,
              "height": 578,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Pr0u_jncv3Cv8_ebf1osPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/2c3245b488f21f067bff7b3714297728.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/factbox-metsera-target-pfizers-novo-170136393.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/factbox-metsera-target-pfizers-novo-170136393.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]